TRULY INT'L (00732) spent 1.08 million Hong Kong dollars to repurchase 1 million shares on December 29th.
Shinri International (00732) announced that the company spent 1.08 million Hong Kong dollars on December 29, 2025 to repurchase 1 million shares at a repurchase price of 1.08 Hong Kong dollars per share.
TRULY INT'L (00732) announced that the company spent 1.08 million Hong Kong dollars to repurchase 1 million shares on December 29, 2025, at a repurchase price of 1.08 Hong Kong dollars per share.
Related Articles
The merger of CHUANGLIAN HOLD (02371) will take effect on January 2, 2026.
CSPC PHARMA (01093): Potent aldosterone synthase inhibitor (SYH2072 tablet) granted clinical trial approval in China.
STERLING GP (01825) plans to offer a premium of approximately 7.5% to sell up to 69.12 million shares. The net proceeds are expected to be approximately 67.7 million Hong Kong dollars.
The merger of CHUANGLIAN HOLD (02371) will take effect on January 2, 2026.
CSPC PHARMA (01093): Potent aldosterone synthase inhibitor (SYH2072 tablet) granted clinical trial approval in China.
STERLING GP (01825) plans to offer a premium of approximately 7.5% to sell up to 69.12 million shares. The net proceeds are expected to be approximately 67.7 million Hong Kong dollars.
